85 FR 170 pgs. 54344-54345 - Foreign-Trade Zone (FTZ) 26—Atlanta; Georgia, Authorization of Production Activity, Janssen Pharmaceuticals Inc. (Pharmaceutical Products) Athens, Georgia

Next Article Next

Type: NOTICEVolume: 85Number: 170Pages: 54344 - 54345

Docket number: [B–25–2020]

FR document: [FR Doc. 2020–19258 Filed 8–31–20; 8:45 am]

Agency: Commerce Department

Sub Agency: Foreign-Trade Zones Board

Official PDF Version: PDF Version

Pages: 54344, 54345

[top]

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-25-2020]

Foreign-Trade Zone (FTZ) 26-Atlanta; Georgia, Authorization of Production Activity, Janssen Pharmaceuticals Inc. (Pharmaceutical Products) Athens, Georgia

On April 29, 2020, Janssen Pharmaceuticals Inc., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 26K, in Athens, Georgia.

[top] The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including

notice in the Federal Register inviting public comment (85 FR 27205-27206, May 7, 2020). On August 27, 2020, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

Dated: August 27, 2020.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2020-19258 Filed 8-31-20; 8:45 am]

BILLING CODE 3510-DS-P